guest ::
| Home > Publications Database > Disease severity across psychiatric disorders is linked to pro-inflammatory cytokines. > print |
| Home > Publications Database > Disease severity across psychiatric disorders is linked to pro-inflammatory cytokines. > print |
| 001 | 279432 | ||
| 005 | 20250720001530.0 | ||
| 024 | 7 | _ | |a 10.1016/j.bbi.2025.06.004 |2 doi |
| 024 | 7 | _ | |a pmid:40505822 |2 pmid |
| 024 | 7 | _ | |a 0889-1591 |2 ISSN |
| 024 | 7 | _ | |a 1090-2139 |2 ISSN |
| 024 | 7 | _ | |a altmetric:178231373 |2 altmetric |
| 037 | _ | _ | |a DZNE-2025-00763 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 150 |
| 100 | 1 | _ | |a Solomon, Pierre |b 0 |
| 245 | _ | _ | |a Disease severity across psychiatric disorders is linked to pro-inflammatory cytokines. |
| 260 | _ | _ | |a Orlando, Fla. [u.a.] |c 2025 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1752486239_23925 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Numerous studies indicate that the traditional categorical classification of severe mental disorders (SMD), such as schizophrenia, bipolar disorders, and major depressive disorders, does not align with the underlying biology of those disorders as they frequently overlap in terms of symptoms and risk factors.This study aimed to identify transdiagnostic patient clusters based on disease severity and explore the underlying biological mechanisms independently of the traditional categorical classification.We utilized data from 443 participants diagnosed with SMD of the PsyCourse Study, a longitudinal study with deep phenotyping across up to four visits. We performed longitudinal clustering to group patients based on symptom trajectories and cognitive performance. The resulting clusters were compared on cross-sectional variables, including independent measures of severity as well as polygenic risk scores, serum protein quantification, miRNA expression, and DNA methylation.We identified two distinct clusters of patients that exhibited marked differences in illness severity but did not differ significantly in age, sex, or diagnostic proportions. We found 19 serum proteins significantly dysregulated between the two clusters. Functional enrichment pointed to a convergence of immune system dysregulation and neurodevelopmental processes.The observed differences in serum protein expression suggest that disease severity is associated with the convergence of immune system dysregulation and neurodevelopmental alterations, particularly involving pathways related to inflammation and brain plasticity. The identification of pro-inflammatory proteins among the differentially expressed markers underscores the potential role of systemic inflammation in the pathophysiology of SMD. These results highlight the importance of considering illness severity as a core dimension in psychiatric research and clinical practice and suggest that targeting immune-related mechanisms may offer promising new therapeutic avenues for patients with SMD. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 536 | _ | _ | |a 899 - ohne Topic (POF4-899) |0 G:(DE-HGF)POF4-899 |c POF4-899 |f POF IV |x 1 |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 2 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Cognitive dysfunction |2 Other |
| 650 | _ | 7 | |a Disease severity |2 Other |
| 650 | _ | 7 | |a Inflammation |2 Other |
| 650 | _ | 7 | |a Multi-omics analysis |2 Other |
| 650 | _ | 7 | |a PLAUR |2 Other |
| 650 | _ | 7 | |a Proteomics |2 Other |
| 650 | _ | 7 | |a Severe mental disorders |2 Other |
| 650 | _ | 7 | |a Transdiagnostic clustering |2 Other |
| 700 | 1 | _ | |a Budde, Monika |b 1 |
| 700 | 1 | _ | |a Kohshour, Mojtaba Oraki |b 2 |
| 700 | 1 | _ | |a Adorjan, Kristina |b 3 |
| 700 | 1 | _ | |a Heilbronner, Maria |b 4 |
| 700 | 1 | _ | |a Navarro-Flores, Alba |b 5 |
| 700 | 1 | _ | |a Papiol, Sergi |b 6 |
| 700 | 1 | _ | |a Reich-Erkelenz, Daniela |b 7 |
| 700 | 1 | _ | |a Schulte, Eva C |b 8 |
| 700 | 1 | _ | |a Senner, Fanny |b 9 |
| 700 | 1 | _ | |a Vogl, Thomas |b 10 |
| 700 | 1 | _ | |a Kaurani, Lalit |0 P:(DE-2719)2812832 |b 11 |u dzne |
| 700 | 1 | _ | |a Krüger, Dennis M |0 P:(DE-2719)2812548 |b 12 |u dzne |
| 700 | 1 | _ | |a Sananbenesi, Farahnaz |0 P:(DE-2719)2811099 |b 13 |u dzne |
| 700 | 1 | _ | |a Pena, Tonatiuh |0 P:(DE-2719)2811063 |b 14 |u dzne |
| 700 | 1 | _ | |a Burkhardt, Susanne |0 P:(DE-2719)2810773 |b 15 |u dzne |
| 700 | 1 | _ | |a Schütz, Anna-Lena |0 P:(DE-2719)2810585 |b 16 |u dzne |
| 700 | 1 | _ | |a Anghelescu, Ion-George |b 17 |
| 700 | 1 | _ | |a Arolt, Volker |b 18 |
| 700 | 1 | _ | |a Baune, Bernhardt T |b 19 |
| 700 | 1 | _ | |a Dannlowski, Udo |b 20 |
| 700 | 1 | _ | |a Dietrich, Detlef E |b 21 |
| 700 | 1 | _ | |a Fallgatter, Andreas J |0 P:(DE-2719)2811701 |b 22 |u dzne |
| 700 | 1 | _ | |a Figge, Christian |b 23 |
| 700 | 1 | _ | |a Juckel, Georg |b 24 |
| 700 | 1 | _ | |a Konrad, Carsten |b 25 |
| 700 | 1 | _ | |a Lang, Fabian U |b 26 |
| 700 | 1 | _ | |a Reimer, Jens |b 27 |
| 700 | 1 | _ | |a Reininghaus, Eva Z |b 28 |
| 700 | 1 | _ | |a Schmauß, Max |b 29 |
| 700 | 1 | _ | |a Spitzer, Carsten |b 30 |
| 700 | 1 | _ | |a Wiltfang, Jens |0 P:(DE-2719)2811317 |b 31 |u dzne |
| 700 | 1 | _ | |a Zimmermann, Jörg |b 32 |
| 700 | 1 | _ | |a Fischer, André |0 P:(DE-2719)2000047 |b 33 |u dzne |
| 700 | 1 | _ | |a Falkai, Peter |b 34 |
| 700 | 1 | _ | |a Schulze, Thomas G |b 35 |
| 700 | 1 | _ | |a Heilbronner, Urs |b 36 |
| 700 | 1 | _ | |a Poschmann, Jeremie |b 37 |
| 773 | _ | _ | |a 10.1016/j.bbi.2025.06.004 |g Vol. 129, p. 359 - 372 |0 PERI:(DE-600)1462491-6 |p 359 - 372 |t Brain, behavior and immunity |v 129 |y 2025 |x 0889-1591 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/279432/files/DZNE-2025-00763%20SUP.zip |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/279432/files/DZNE-2025-00763.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/279432/files/DZNE-2025-00763.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:279432 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 11 |6 P:(DE-2719)2812832 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 12 |6 P:(DE-2719)2812548 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2811099 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2811063 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 15 |6 P:(DE-2719)2810773 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 16 |6 P:(DE-2719)2810585 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 22 |6 P:(DE-2719)2811701 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 31 |6 P:(DE-2719)2811317 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 33 |6 P:(DE-2719)2000047 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF4-890 |0 G:(DE-HGF)POF4-899 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-800 |4 G:(DE-HGF)POF |v ohne Topic |x 1 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 2 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-19 |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b BRAIN BEHAV IMMUN : 2022 |d 2024-12-19 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BRAIN BEHAV IMMUN : 2022 |d 2024-12-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-19 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-19 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-19 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2024-12-19 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-19 |
| 920 | 1 | _ | |0 I:(DE-2719)1410002 |k AG Fischer |l Epigenetics and Systems Medicine in Neurodegenerative Diseases |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1440016 |k Bioinformatics Unit (Göttingen) |l Bioinformatics and Genome Dynamics Core (Göttingen) |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1410004 |k AG Sananbenesi |l Genome Dynamics in Neurodegenerative Diseases |x 2 |
| 920 | 1 | _ | |0 I:(DE-2719)1410006 |k AG Wiltfang |l Molecular biomarkers for predictive diagnostics of neurodegenerative diseases |x 3 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1410002 |
| 980 | _ | _ | |a I:(DE-2719)1440016 |
| 980 | _ | _ | |a I:(DE-2719)1410004 |
| 980 | _ | _ | |a I:(DE-2719)1410006 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|